-
Malians tell of torture and killings by army, Russian fighters
-
EU-China spacecraft takes off on mission to probe solar winds
-
Under Trump pressure, EU eyes deal to end trade standoff
-
'We're here solely to play football,' insists North Korean coach
-
Putin trip aims to show China ties unshakeable after Trump pomp
-
Hanoi hits the brakes on petrol bike ban
-
Japan economy grows faster than expected in first quarter
-
World Cup glory attracts superstar coaches into international battle
-
Stuttering Sabalenka seeks to set down marker at Roland Garros
-
'Little' Freiburg chasing glory in debut European final
-
Villa inspired by former heroes as they target Europa League glory
-
Irrepressible Sinner primed for career Grand Slam at Roland Garros
-
China market for Nvidia AI chips to open 'over time': Huang
-
Asian markets cautious, oil dips after Trump holds off on Iran attack
-
Three killed in San Diego mosque shooting, both suspects dead
-
Love, lust and gnomes as top UK flower show bursts into bloom
-
Fans of historic DC park wary of Trump plan to 'beautify' city
-
As bee population collapses, US apiarists fear research cuts
-
Lights out for Cuban students as blockade bites
-
Campaigners warn Italy's gutted rape bill could help assailants
-
Libyan ex-prison boss faces ICC war crimes hearing
-
Argentine scientists lay first traps in hantavirus hunt
-
Star of Rome's 'sexy priest' calendar admits: 'I was never a priest'
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 19
-
Harry Styles fans to splash over £1 bn on London concerts: Barclays
-
Bolivia protest sees violent clashes, looting in La Paz
-
Trump says held off on new Iran attack, upbeat for agreement
-
Los Angeles World Cup workers vow strike over ICE guarantees
-
Three killed in San Diego mosque shooting, two attackers dead
-
US to screen for Ebola at airports, one American in DR Congo infected
-
Aussie Scott officially set for 100th straight major at US Open
-
Pep Guardiola to leave Man City at end of the season - reports
-
Neymar back in Brazil squad for fourth World Cup
-
Arsenal on the brink of Premier League title after nervy Burnley win
-
World Cup winner Pavard confirms Marseille exit
-
Trump says holding off on new Iran attack
-
Cuba warns of 'bloodbath' if US attacks; Washington adds sanctions
-
Trump says delaying Iran attack at request of Gulf leaders
-
Cuba warns of 'bloodbath' if US attacks and Washington issues sanctions
-
After mayor's murder, Mexico battles to bring peace
-
Trump admin creates $1.7 bln fund to compensate allies prosecuted under Biden
-
Pelicans name Mosley as coach, two weeks after Magic firing
-
Hyderabad qualify for IPL play-offs along with Gujarat
-
'Girl in the River Main' identified 25 years on, father arrested
-
Musk loses blockbuster OpenAI suit as jury says too late
-
SNC Scandic Coin and Biconomy: Regulated real-world assets meet global trading infrastructure
-
Judge allows gun as evidence in Mangione healthcare exec murder trial
-
First attack on Arab nuclear site sends warning to Gulf, US
-
Oil rises, bond yields weigh on stocks
-
Hormuz tanker traffic edges higher after wartime low
Dalrada Financial Corporation's Deposition Technology Makes Spectroptix(R) Available for Advance Ordering
Deptec's plasma spectrometer is primed to play an integral role in the booming semiconductor manufacturing and thin-film sectors.
Dalrada Financial Corporation(OTC PINK:DFCO), "Dalrada," "the Company"), announced today that Spectroptix®, a proprietary advanced plasma spectrometer developed by its subsidiary, Deposition Technology ("Deptec,"), is now available for advance ordering.
The one-of-a-kind spectrometer is designed for precise element detection in vacuum chambers during deposition or semiconductor manufacturing processes, allowing for the integration of advanced plasma spectroscopy. This specialized tool also offers a host of other key features and benefits, according to Brian Bonar, Dalrada's Chairman and CEO.
"Spectroptix® is the ideal machine for the semiconductor industry," said Bonar. "For starters, it can be integrated into various vacuum-based processes, from thin film coatings to plasma-enhanced CVD and PVD systems. It's also quite easy to operate. Spectroptix® will be a real game-changer in the microchip and semiconductor world and we're quite thrilled to offer pre-ordering for our clients."
Deptec's Spectroptix® delivers real-time actionable data on materials within each vacuum chamber during the deposition process, ensuring higher accuracy, efficiency, and process control. Other benefits of the advanced spectrometer include:
Plasma creation: a background plasma independent of the deposition process, ensuring that no process contamination or interference occurs during analysis.
Enhanced Process Control: using real-time data, Spectroptix® enables precise control over deposition environments, allowing for on-the-fly adjustments to gas flow or composition.
User-Friendly Interface: intuitive software control that allows remote operation for operators to visualize and analyze light spectrum data for efficient optimization.
Preferred over Residual Gas Analyzers (RGAs): more cost-effective solution than RGAs, plus RGAs do not come standard with vacuum technology.
Deptec's Spectroptix® is particularly well-suited for applications requiring ultra-thin films and sensitive optical coatings, like semiconductor manufacturing, microelectronics, optoelectronics, advanced material processing, and more. Future target markets include pharmaceuticals, aerospace/defense, materials science, nuclear industries, and food and beverage.
With a mature product line firmly in place within the deposition technology marketplace, Deptec has its sights on further expanding its unique portfolio, adding robust solutions to include a new chemical vapor deposition (CVD) platform-the EVOS CVD system-which would join the company's popular Novellus C1 upgrade kit for legacy CVD machines.
"With our increased production and installation capabilities plus the rollout of new products providing even greater opportunities, making Spectroptix® available for pre-ordering is just the beginning," added Bonar.
About Dalrada Financial Corporation
Dalrada Financial Corporation(OTC PINK:DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy, Physical and Chemical Vapor Deposition for Semiconductors, and Health Care sectors. Dalrada's core segments include Dalrada Climate Technology, which offers cutting-edge heat pump and energy sustainability technology for industrial and residential applications; Deptec, an international leader in deposition technology and manufacturing that repurposes and sells proprietary semiconductor technology for clean energy applications; and Genefic Specialty Pharmacy, which provides end-to-end prescription and specialty pharmacy services as well as patient advocacy and support.
Dalrada consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.
For more information, please visit www.dalrada.com, and follow us on LinkedIn, Facebook, Twitter, and YouTube.
About Deposition Technology
Deposition Technology (Deptec) is a wholly-owned subsidiary of Dalrada Financial Corporation(OTC PINK:DFCO), and an international leader in precision manufacturing, specializing in thin-film deposition including PVD (Physical Vapor Deposition) and CVD (Chemical Vapor Deposition) processing and equipment.
Founded in 2004, Deptec has expanded to specialize in upgrading legacy tools, including Novellus Concept One, and delivering innovative solutions like Spectroptix for advanced material detection. The company's products and services are designed to enhance the performance, reliability, and cost-efficiency of manufacturing processes in the semiconductor, MEMS, and optoelectronics industries.
Forward-Looking Statements
Statements contained in this press release, other than statements of historical fact, particularly statements relating to cost reductions and the anticipated pre-tax savings from the cost reduction program, restructuring costs, footprint rationalization, simplifying and streamlining our operations, reducing complexity, enhancing the speed of decision-making, leveraging our sourcing capabilities and the timing of implementation and completion of the cost reduction program, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of management based on information available to us at the time such statements are made. These statements, which are generally identifiable by the use of the words "will," "believe," "expect," "intend," "anticipate," "estimate," "forecast," "project," "plan," and similar expressions, are subject to certain risks and uncertainties, are made as of the date hereof, and we undertake no duty or obligation to update them. Forward-looking statements are subject to the occurrence of many events outside the Company's control and actual results and the timing of events may differ materially from those suggested or implied by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the US Securities and Exchange Commission ("SEC"), including its annual report on Form 10-K.
Media contact: Michael Eslinger ([email protected])
# # #
SOURCE: Dalrada Financial Corporation
D.Moore--AMWN